Login
Subscribetax inversion
Pfizer-Allergan Merger Scrapped
Bob Grant | Apr 7, 2016 | 2 min read
A move by the US federal government to close tax loopholes that encourage “tax inversions” likely spooked the companies out of the multibillion dollar deal.